TheraRadar
← Back
Data updated: Mar 29, 2026

GENUS LIFESCIENCES

MetabolicOncology
Pharma

GENUS LIFESCIENCES is a pharmaceutical company focused on Metabolic, Oncology. Key products include POKONZA.

1981
Since
9
Drugs
-
Trials
181
Approved (2yr)

Key Drugs

POKONZA
potassium chloride
2 indications · 2014

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 67%
2 drugs
Oncology 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Merck big-pharma
Oncology, Metabolic
Johnson & Johnson big-pharma
Oncology, Metabolic
Sanofi big-pharma
Metabolic, Oncology
Eli Lilly big-pharma
Metabolic, Oncology
Bayer big-pharma
Oncology, Metabolic